Merit Medical Systems | MMSI - Assets


Merit Medical Systems reported $2.69B in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
3M USD 37.73B 122M Dec/2025
Abbott USD 86.71B 2.53B Dec/2025
AngioDynamics USD 285.41M 6.14M Feb/2025
Anika Therapeutics USD 189.44M 1.76M Sep/2025
AtriCure USD 654.18M 18.74M Dec/2025
Baxter International USD 20.06B 1.01B Dec/2025
Becton, Dickinson and Co. USD 54.84B 484M Dec/2025
Boston Scientific USD 43.67B 966M Dec/2025
Cooper Companies USD 12.42B 29.4M Dec/2025
Dexcom USD 6.34B 1.16B Dec/2025
Edwards Lifesciences USD 13.27B 216.5M Sep/2025
Globus Medical USD 5.3B 207.12M Dec/2025
Haemonetics USD 2.49B 48.73M Dec/2025
Hologic USD 9.18B 165.8M Dec/2025
ICU Medical USD 4.05B 52.39M Dec/2025
Insulet USD 3.19B 161.1M Dec/2025
Integra LifeSciences USD 3.6B 44.45M Dec/2025
J&J USD 199.21B 6.39B Dec/2025
Medtronic USD 91.35B 374M Sep/2025
Merit Medical Systems USD 2.69B 54.92M Dec/2025
Olympus JPY 1.46T 73.12B Dec/2025
Pfizer USD 208.73B 2.64B Sep/2025
STAAR Surgical USD 451.68M 4.68M Dec/2025
Stryker USD 47.84B 787M Dec/2025
Surmodics USD 178.56M 1.15M Sep/2024
Tandem Diabetes Care USD 881.11M 6.46M Dec/2025
Teleflex USD 6.95B 924.7M Dec/2025
Terumo JPY 2.26T 362.12B Dec/2025
Zimmer Biomet Holdings USD 23.09B 396.3M Dec/2025